Scarica l'app Stockscreener
4.64
3.53%
-0.17
Dopo l'orario di chiusura:
4.64
Precedente Chiudi:
$4.81
Aprire:
$4.8
Volume 24 ore:
181.09K
Relative Volume:
0.91
Capitalizzazione di mercato:
$108.84M
Reddito:
$7.94M
Utile/perdita netta:
$-21.13M
Rapporto P/E:
-4.2891
EPS:
-1.0818
Flusso di cassa netto:
$-16.17M
1 W Prestazione:
+4.74%
1M Prestazione:
-11.79%
6M Prestazione:
-6.45%
1 anno Prestazione:
-23.68%
Intervallo 1D:
$4.57
$4.80
Intervallo di 1 settimana:
$4.43
$4.8391
Portata 52W:
$3.7101
$7.75
Coya Therapeutics Inc Stock (COYA) Company Profile
Nome
Coya Therapeutics Inc
Settore
Industria
Telefono
650.739.3939
Indirizzo
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Compare COYA vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
4.64 | 100.04M | 7.94M | -21.13M | -16.17M | -1.0818 |
VRTX
Vertex Pharmaceuticals Inc
|
523.91 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
808.05 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
866.11 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.97 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
359.00 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-09 | Iniziato | Lake Street | Buy |
| 2024-12-04 | Iniziato | D. Boral Capital | Buy |
Coya Therapeutics Inc Borsa (COYA) Ultime notizie
Coya Therapeutics (NASDAQ: COYA) holder discloses 3.3% stake in amended filing - Stock Titan
Coya Therapeutics Inc (COYA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Coya Therapeutics Inc (COYA) Balance Sheet - TradingKey
Coya Therapeutics Inc (COYA) Cash Flow - TradingKey
COYA|Coya Therapeutics Inc|Price:4.250|Chg%:-0.130 - TradingKey
Coya Therapeutics Inc (COYA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Coya Therapeutics Inc (COYA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Coya Therapeutics Inc (COYA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Coya Therapeutics Market Sentiment - Benzinga España
Coya Therapeutics Inc (COYA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Coya Therapeutics Inc (COYA) Income Statement - TradingKey
Coya Therapeutics, Inc. Revenue Breakdown – NASDAQ:COYA - TradingView
Coya Therapeutics Inc (COYA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Discipline and Rules-Based Execution in COYA Response - Stock Traders Daily
Price to book forward of Coya Therapeutics, Inc. – NASDAQ:COYA - TradingView
Price to earnings forward of Coya Therapeutics, Inc. – NASDAQ:COYA - TradingView
Price to sales forward of Coya Therapeutics, Inc. – NASDAQ:COYA - TradingView
Coya Therapeutics (COYA) Dips 1.3% as Stock Tests Key Support LevelsBear Pennant - dars.gov.et
Coya Targets ALS Trial Readout in Q1 2027, H.C. Wainwright Sets US$18 Price Target - Streetwise Reports
Houston ALS Biotech Coya Eyes 2028 Approval Path - Streetwise Reports
Coya Therapeutics(COYA) Stock Options Chain | Quotes & News - Moomoo
Coya Therapeutics (COYA) Slips 1.87% as Stock Tests Key Support Near $5.00Triple Top - dars.gov.et
Coya Therapeutics to Host Virtual Webinar on the Intersection of Repetitive Head Trauma, Brain Inflammation and Neurodegenerative Disease - AOL.com
COYA Q1 2026 Earnings: Narrower-Than-Expected Loss as Pipeline AdvancesProfitability Analysis - dars.gov.et
Roth MKM Maintains Coya Therapeutics(COYA.US) With Buy Rating, Maintains Target Price $12 - Moomoo
Coya Therapeutics Dips 2.3% as Stock Tests Key Support at $5.42Max Pain Level - dars.gov.et
Is Coya Therapeutics, Inc. (COYA) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Behavioral Patterns of COYA and Institutional Flows - Stock Traders Daily
Coya Therapeutics, Inc. Actuals & Estimates (NASDAQ:COYA) - TradingView
Coya Therapeutics, Inc. Actuals & Estimates (BOATS:COYA) - TradingView
Coya Therapeutics Price Target Maintained With a $14.00/Share by Chardan Capital - Moomoo
H.C. Wainwright Remains a Buy on Coya Therapeutics, Inc. (COYA) - The Globe and Mail
Coya Therapeutics, Inc. Reports 2026 Annual Meeting Results and Company Information (NASDAQ: COYA) - Minichart
Coya Therapeutics Shareholders Back Board, Auditor at Meeting - TipRanks
Coya Therapeutics (NASDAQ: COYA) shareholders back board nominees and 2026 auditor - Stock Titan
COYA Forecast — Price Target — Prediction for 2027 - TradingView
H.C. Wainwright Maintains Coya Therapeutics(COYA.US) With Buy Rating, Maintains Target Price $18 - Moomoo
Coya Therapeutics (COYA) Investor update Summary - Quartr
COYA Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive SentimentEarnings Recovery Stocks - dars.gov.et
Number of shareholders of Coya Therapeutics, Inc. – NASDAQ:COYA - TradingView
COYA Therapeutics Inc. (COYA) Edges Higher as Stock Hovers Near ResistanceRip Sell Trade - dars.gov.et
Exosomes Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Innovex Therapeutics, Coya Therapeutics, EV Therapeutics, Endosome Therapy StemXO - Barchart.com
COYA Technical Analysis & Stock Price Forecast - Intellectia AI
COYA Q1 2026 Earnings: Wider-Than-Expected Loss Still Beats Estimates as Biotech Advances PipelineNext Quarter Guidance - dars.gov.et
Coya Therapeutics to Present ALSTARS Trial Design at the ENCALS 2026 Meeting - BioSpace
Coya Therapeutics Inc (COYA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Coya Therapeutics Inc (COYA) Institutional Confidence - TradingKey
Coya Therapeutics Inc (COYA) Valuation: PE, PB & Fair Value Analysis - TradingKey
COYA Maintains Buy Rating by Chardan Capital -- Price Target at $14 - GuruFocus
Coya Therapeutics (COYA) Gains 2.16% as Stock Nears Key Resistance ZoneDip Buy Trade - newsline.com
Oruka Therapeutics, Inc. (ORKA) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance
Coya Therapeutics Inc Azioni (COYA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.82%
1.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):